Evidence map›Paper›PMID 41027310›Full record

ArticleEBioMedicine2025

Phenotypic and epigenetic profiles of circulating NK cells in spontaneous HIV-1 controllers.

Alisa Huber, Albert L Groenendijk, Adriana Navas, Nadira Vadaq, Suzanne D E Ruijten, Vasiliki Matzaraki, Ezio T Fok, Aysel Gurbanova, Wilhelm A J W Vos, Marc J T Blaauw and 16 more

Abstract read
In one paragraph

Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The elite controller phenotype.Current opinion in HIV and AIDS · 2026
    Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Alisa HuberDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Albert L GroenendijkDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands; Department of Internal Medicine and Department of Medical Microbiology and Infectious Diseases, ErasmusMC, Erasmus University, Rotterdam, the Netherlands.
Adriana NavasDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Nadira VadaqDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Suzanne D E RuijtenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Vasiliki MatzarakiDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Ezio T FokDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Aysel GurbanovaLaboratory of Medical Immunology (LMI), Radboudumc, Nijmegen, the Netherlands.
Wilhelm A J W VosDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands; Department of Internal Medicine and Infectious Diseases, OLVG, Amsterdam, the Netherlands.
Marc J T BlaauwDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands; Department of Internal Medicine and Infectious Diseases, Elizabeth-Tweesteden Ziekenhuis, Tilburg, the Netherlands.
Louise E van EekerenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Maartje C P Jacobs-CleophasDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Janneke StalenhoefDepartment of Internal Medicine and Infectious Diseases, OLVG, Amsterdam, the Netherlands.
Marvin BerrevoetsDepartment of Internal Medicine and Infectious Diseases, Elizabeth-Tweesteden Ziekenhuis, Tilburg, the Netherlands.
Renate van der MolenLaboratory of Medical Immunology (LMI), Radboudumc, Nijmegen, the Netherlands.
Arnold van der MeerLaboratory of Medical Immunology (LMI), Radboudumc, Nijmegen, the Netherlands.
Marien I de JongeLaboratory of Medical Immunology (LMI), Radboudumc, Nijmegen, the Netherlands.
Joost H A MartensDepartment of Cell Biology, Faculty of Science, Radboud University, Nijmegen, the Netherlands.
Casper RokxDepartment of Internal Medicine and Department of Medical Microbiology and Infectious Diseases, ErasmusMC, Erasmus University, Rotterdam, the Netherlands.
Annelies VerbonDepartment of Internal Medicine and Department of Medical Microbiology and Infectious Diseases, ErasmusMC, Erasmus University, Rotterdam, the Netherlands.
Jan van LunzenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Hans J P M KoenenLaboratory of Medical Immunology (LMI), Radboudumc, Nijmegen, the Netherlands.
Mihai G NeteaDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Germany.
Andre J A M van der VenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands.
Leo A B JoostenDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands; Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Jéssica C Dos SantosDepartment of Internal Medicine and Radboudumc Community for Infectious Diseases (RCI), Radboudumc, Nijmegen, the Netherlands. Electronic address: jessica.dossantos@radboudumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNK cells play a key role in eliminating HIV-infected cells, but it is unclear whether there are specific NK cell receptor signatures in spontaneous HIV controllers.

methodsWe conducted a cross-sectional analysis of circulating NK cell phenotypes in people living with HIV (PLHIV), divided into spontaneous HIV controllers (HIC), normal progressors on antiretroviral therapy (non-HIC), and first-degree HIV-negative family members. Using supervised and unsupervised flow cytometry, we assessed NK cell markers and receptors. We performed an epigenetic analysis of H3K4me3 chromatin enrichment in NK cells from both HIC and non-HIC and measured IFNγ, Perforin and CD107a expression in NK cells upon stimulation with IL-2/IL-15, K562 cells, and IFNα. Additionally, we conducted a genome-wide association study (GWAS) and quantitative trait locus (QTL) mapping using data from HIC and non-HIC part of the 2000HIV study.

findingsHIV controllers had higher levels of CD56

interpretationThese results suggest that spontaneous HIV control is associated with an NK cell memory phenotype, shaped by HIV infection, epigenetic modifications, and genetic factors.

fundingThe authors are part of the 2000HIV study, which is supported by ViiV Healthcare.

Indexed as

Epigenesis, GeneticHIV-1HIV InfectionsKiller Cells, NaturalAdultBiomarkersCross-Sectional StudiesFemaleGenome-Wide Association StudyHumansImmunophenotypingMaleMiddle AgedPhenotypeQuantitative Trait LociBiomarkersHIVInnate immune memoryNK-cellsNormal progressors on ARTSpontaneous HIV-controllers

Identifiers

PMID41027310
PMCPMC12513069

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.